NADPH-dependent drug redox cycling and lipid peroxidation in microsomes from human term placenta.
1. NADPH-dependent iron and drug redox cycling, as well as lipid peroxidation process were investigated in microsomes isolated from human term placenta. 2. Paraquat and menadione were found to undergo redox cycling, catalyzed by NADPH:cytochrome P-450 reductase in placental microsomes. 3. The drug redox cycling was able to initiate microsomal lipid peroxidation in the presence of micromolar concentrations of iron and ethylenediaminetetraacetate (EDTA). 4. Superoxide was essential for the microsomal lipid peroxidation in the presence of iron and EDTA. 5. Drastic peroxidative conditions involving superoxide and prolonged incubation in the presence of iron were found to destroy flavin nucleotides, inhibit NADPH:cytochrome P-450 reductase and inhibit propagation step of lipid peroxidation. 6. Reactive oxo-complex formed between iron and superoxide is proposed as an ultimate species for the initiation of lipid peroxidation in microsomes from human term placenta as well as for the destruction of flavin nucleotides and inhibition of NADPH:cytochrome P-450 reductase as well as for impairment of promotion of lipid peroxidation under drastic peroxidative conditions.
Byczkowski
J Z
JZ
Florida Toxicology Research Center, College of Public Health, University of South Florida, Tampa 33612.
Kulkarni
A P
AP
D005260:Female; D006801:Humans; D015227:Lipid Peroxidation; D008054:Lipid Peroxides / Q000096:biosynthesis; D008861:Microsomes / Q000378:metabolism*; D009249:NADP / Q000378:metabolism*; D009251:NADPH-Ferrihemoprotein Reductase / Q000378:metabolism; D010084:Oxidation-Reduction / Q000187:drug effects; D010269:Paraquat / Q000378:metabolism; D010920:Placenta / Q000378:metabolism*; D011247:Pregnancy; D014812:Vitamin K / Q000378:metabolism
D008054:Lipid Peroxides; D014812:Vitamin K; D009249:NADP; D009251:NADPH-Ferrihemoprotein Reductase; D010269:Paraquat